EventsThe 2nd International Electronic Conference on Biomolecules
Published
with-doi10.3390/IECBM2022-13400 (registering DOI)
This submission belongs to the session D. Biomolecules: Lipids of the event The 2nd International Electronic Conference on Biomolecules
Published date
01 Nov, 2022
Academic Editor
author-avatarRobert Stahelin
Citation
Zhengwei Huang, Cheng Ma, Ying Huang, Xuejuan Zhang, Chuanbin Wu, Xin Pan, Formulation Screening of Stearic Acid-based Solid Lipid Microparticles on Gram-scale, in Proceedings of The 2nd International Electronic Conference on Biomolecules, 1 November–15 November 2022, MDPI: Basel, Switzerland, doi: 10.3390/IECBM2022-13400
Share
Email
Facebook
Twitter
LinkedIn

Formulation Screening of Stearic Acid-based Solid Lipid Microparticles on Gram-scale

image
Cheng Ma 2
image
image
1. College of Pharmacy, Jinan University, China
2. The University of Hong Kong
3. College of Pharmacy, Jinan University
4. School of Pharmaceutical Sciences, Sun Yat-sen University
Abstract

As a nature-derived lipid, stearic acid (SA) has been widely recognized as a safe pharmaceutical excipient. One of the most potent application of SA in pharmaceutical aspect is its feasibility for constructing a versatile drug delivery system with translational potential, solid lipid microparticles (SLM). In this work, the formulation of SA-based SLM was screened and optimized on gram-scale (> 2 g), so as to boost the industrialization of related products. Melt-sonication method was employed for SLM production. Four critical parameters were set at five levels, viz. Lipid amount 2.0~4.0 g, sonication time 10~50 min, aqueous solution volume 60~300 mL and surfactant concentration 0~1.00% (W/V), and SLM were accordingly prepared. Reproducibility and yield were two criteria for formulation screening, and a high reproducibility and yield would be satisfactory. Herein, reproducibility and yield was determined by size deviation (reflexed by an index C) and recovered weight (reflexed by an index Y), respectively. To be specific, C = RSD2Size + RSD2PDI and Y = ma- mb, where RSDSize, RSDPDI, ma and mb represented relative standard deviation of particle size, relative standard deviation of polydispersity index, initial weight and obtained weight, respectively. The results showed that lipid amount 2.5 g, sonication time 30 min, aqueous solution volume 120 mL and surfactant concentration 0.75% (W/V) established the optimal formulation. We believe that this work can provide useful information for the (pre-)industrial-scale development of SA-based SLM.

Keywords
Solid Lipid Microparticle
Formulation Screening
Gram-scale
Pharmaceutical Translation
Manuscript
Structure, properties and biological activity of chitosan salts with L- and D-aspartic acid
Targeting Heme Oxygenase in Ferroptosis: a Novel Insight in Cancer Therapy